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Background: Extended spectrum beta-lactamase (ESBL)-producing Escherichia coli (E. coli)
causing urinary tract infections often belong to sequence type 131 (ST131), serotype O25,
carrying blaCTX-M-15.
Aim: The main aim of this study was to examine the conjugational frequencies of E. coli
with plasmids carrying blaCTX-M-15 to E. coli isolates from the fecal ﬂora of healthy humans
to determine whether ST131 is more likely to uptake or donate ESBL resistance compared to
other E. coli clones.
Methods: Donors and recipients were all clinical isolates and did not harbor plasmids with
identical incompatibility groups (Inc-groups) based on in silico analyses of Inc-groups and
restriction/modiﬁcation systems (R/M-systems). The in vitro conjugation experiments were
performed as ﬁlter conjugation with veriﬁcation of transconjugants by random ampliﬁed
polymorphic DNA (RAPD) PCR and blaCTX-M-15 PCR.
Results: The frequencies of conjugation with blaCTX-M-15-carrying plasmids were found to
be very rare with detectable conjugation frequencies in the range of 4x10−9–7x10−7 trans-
conjugants/recipient. Recipients of O25/ST131 type yielded signiﬁcantly lower conjugation
frequencies compared to recipients of other O-types (P=0.004). The applied ST131/O25
donors did not yield detectable levels of transconjugants regardless of the applied recipient.
Presence of sub-MIC levels of ampicillin increased plasmid transfer frequencies x100 fold
(P=0.07).
Conclusion: The results indicate that blaCTX-M-15 is rarely transferred by conjugation to
E. coli isolates of the intestinal ﬂora, even when the gene is plasmid-borne.
Keywords: horizontal gene transfer, antimicrobial resistance, Escherichia coli, molecular
typing, ST131, faecal isolates
Introduction
Escherichia coli is a part of the normal intestinal ﬂora of healthy individuals with
increasing levels of extended-spectrum beta-lactamase (ESBL) resistance in many
parts of the world.1,2 The prevalence of ESBL producing E. coli (EPE) has been
increasing in Denmark since the early 2000s but is now stagnating at 4–7% in blood
and urine isolates.3,4 In Denmark, a study of E. coli causing UTI in general practice
showed that E. coli belonging to sequence type 131 (ST131) clearly dominated the
ESBL-producing population, almost always belonging to serotype O25 and, as seen in
other parts of the world, most frequently carrying blaCTX-M-15.
2,5,6 Hence, ESBL
production seems to be correlated to speciﬁc ST and O-type in E. coli. The genes
encoding ESBLs have been shown to transfer horizontally from one bacterium to
another via conjugation,7 which is inﬂuenced by compatibility of the mating pair and
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presence of restriction/modiﬁcation systems in the recipient
cell.8,9 In vivo, this usually occurs in the human intestine
which is a large reservoir for genetic material.10 Selective
pressure from antibiotic concentrations below the minimal
inhibitory concentration (MIC) has been found to affect
transfer of resistance plasmids.11
In this study, we investigated the conjugational transfer
of ESBL resistance encoded by blaCTX-M-15 and a possible
association of conjugal frequencies to O-type and ST of
the recipient. This was investigated in a wide range of
fecal E. coli of different O-types and STs, including the
prevalent ST131, all collected from general practices. This
could reveal whether transfer of ESBL is lineage speciﬁc
and merely seen in a few successful STs, like ST131, as
well as predict the frequency of plasmid transfer to fecal
E. coli from healthy adults. Such a study has, to our
knowledge, not been performed previously with fecal
E. coli of human origin as recipients.
Materials and methods
The donor isolates used in this study were E. coli collected
from urine samples from general practice, previously
described by Hertz et al.6 The recipient isolates were from
a collection of fecal E. coli from younger women previously
described by Nielsen et al.12 These isolates constituted
a variety of STs, O-types and incompatibility groups (Inc-
groups) (Table 1) with ampicillin MIC<8mg/L. Whole gen-
ome sequencing analyses were conducted on 29 possible
donors and 19 possible recipients which were previously
sequenced from Illumina paired-end and mate-pair libraries
described in detail by Nielsen et al.13 Isolates sequenced in this
study were sequenced (Illumina) using paired-end libraries
(Nextera XT library kit) and for a subset of isolates (N=13)
we were able to create mate-pair libraries (Nextera Mate Pair
Sample Preparation Kit) in addition to paired-end libraries
(genomic details for all isolates in Table S1). The DNA was
extracted using DNeasy blood and tissue kit. Assembly was
created using AllPaths-LG and the genomes were annotated
with Prokka. The genomes were analyzed with Plasmidﬁnder
1.3, MLST 2.0 and SerotypeFinder 2.0 (all from cbs.dtu.dk)
and existence of restriction/modiﬁcation (R/M) systems in
recipient strains was analyzed in REBASE and using
GenBank followed by BLAST (80% similarity and query
coverage).14 Three donor strains of different MLST type,
serotypes and Inc-groups (Hvi45, Hvi132 and Hvi09) were
selected for conjugation based on the genomic analyses and
found to be compatible with 9, 11 and 9 recipients, respec-
tively (Table 1). Additionally, conjugation to a laboratory K12
E. coli strain (ALO1319) was included for comparison. The
recipients had no natural antibiotic drug resistance to distin-
guish them from the donors; thus, rifR,strR recipients were
produced as described previously.15
For the conjugation, donor and recipient strains (Table 1 for
performed combinations) were grown in LB broth overnight at
37°C with DNase (10 mL/L) (DNase I, Sigma Aldrich
Denmark, Brøndby, Denmark) and mixed 1:1 and 100 µL
was added to a sterile ﬁlter (0.22µM GSTF, Merck Millipore,
Darmstadt, Germany) on a 5% blood agar plate (SSI
Diagnostica, Hillerød, Denmark) and incubated overnight at
37°C. The cells were suspended from the ﬁlter in 0.9% saline
by vortexing and plated in duplicates on agar plates containing
rifampicin (100 mg/L)/streptomycin (100 mg/L), ampicillin
(1000 mg/L) and rifampicin (100 mg/L)/streptomycin
(100 mg/L)/ampicillin (1000 mg/L) (all from Sigma Aldrich,
Brøndby, Denmark), respectively, after appropriate dilution in
0.9% saline. All conjugation experiments were performed in
duplicates and included relevant positive and negative con-
trols, and after 48 hrs, the plateswere counted andﬁve colonies
were picked from each agar plate for veriﬁcation by PCR for
blaCTX-M-15
5 and a random ampliﬁed polymorphic DNA
(RAPD) PCR16 to distinguish true transconjugants from
mutated donor strains. For a subset of isolates, we performed
liquid conjugation with single and double antibiotic selective
plating, as described by Johnson et al.17
The plasmid transfer experiments were repeated with
one donor (Hvi15) and three recipient strains (KTE72,
KTE144, KTE168) under selective pressure on agar plates
with ampicillin (0.75 mg/L).
Results and discussion
The aim of this study was to investigate the conjugative
transfer of ESBL production caused by blaCTX-M-15 to fecal
E. coli with different O-types and STs. Opposite from pre-
vious studies, this study applied recipients of fecal human
origin instead of laboratory strains. All this with the purpose
of indicating the likelihood of horizontal spread of ESBL
resistance to other fecal E. coli, as laboratory strains have
been described as poor models for in vivo plasmid transfer
frequencies.18,19 The fecal isolates were prepared for conju-
gation by introducing not only rifampicin resistance but also
streptomycin resistance to perform appropriate selection.
Introduction of only one resistance marker prior to conjuga-
tion as described elsewhere17 lead to selection of rifampicin-
resistant donors on the transconjugant plate (veriﬁed by
RAPD PCR), whereas no donor mutants were grown on the
plate when both rifampicin and streptomycin were applied
Thingholm et al Dovepress
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(data not shown). This demonstrates the importance of dou-
ble antimicrobial selection of transconjugants and molecular
veriﬁcation of transconjugants by, eg, RAPD PCR in order
not to report falsely high conjugation frequencies.
The mate-pair genomes yielded almost complete assem-
bly of plasmid content on the same scaffold, and from these
genomes, we were able to predict whether blaCTX-M-15 was
carried on a plasmid, and hence transferable, or was
anchored in the chromosome unlikely to conjugate. In silico
investigation identiﬁed only a few donors of ST131/O25
where blaCTX-M-15 was surrounded by plasmid material (4/
12). The remaining isolates including 8 of 11 isolates
belonging to the disseminating ﬁmH30 subclone carried
blaCTX-M-15 on the chromosome surrounded by transpo-
sases. Based on the genomic sequences, the three selected
donors for conjugation experiments carried blaCTX-M-15 on a
plasmid and not anchored in the chromosome.
We investigated the conjugation abilities of different
blaCTX-M-15-carrying donors with compatible recipients.
Despite a very thorough genomic investigation for optimal
donors, the results illustrate very low conjugation frequen-
cies for all three donors (Table 1). The donors Hvi132 and
Hvi09, belonging to O25/ST131 did not produce any detect-
able transconjugants with ﬁlter (Table 1) nor liquid conju-
gation (data not shown), despite carrying blaCTX-M-15 on
a plasmid. The donor Hvi15 (O28/ST10) conjugated with
several recipients with frequencies of 10−9–10−7/recipient
and 10−10–10−7/donor (Table 1). For this donor, the median
conjugation frequency was lower with recipients of O25/
ST131 (KTE49, Hvi138) compared to other O- and ST-
types (Figure 1A, Table 1, P=0.004). In addition,
conjugation with a ST131/O25/ﬁmH30 donor with
blaCTX-M-15 situated in the genome surrounded by transpo-
sases was also investigated with several different recipients,
but showed frequencies below the detection limit similar to
the remaining ST131 donors (data not shown), as expected
due to the genomic positioning of blaCTX-M-15. This geno-
mic variant constituted 7 of 13 ST131/O25/ﬁmH30 donors
with high-quality mate-pair assemblies.
Conclusively, the isolates tested had lower conjugation
frequencies when ST131/O25 donors or recipients were
used. Several conjugation studies have been performed
elsewhere using ESBL-producing E. coli strains as donors,
which showed conjugation frequencies of ESBL plasmids
between 10−7 and 10−2 per donor cell applying laboratory
recipients.17,20,21 In these studies, only one antibiotic was
applied for recipient selection and/or the post-
conjugational veriﬁcation of transconjugants was limited
or even absent, which both could explain the different
results obtained in those studies.
In the present study, the conjugative ability of blaCTX-M-15
differs with O-type and ST of the recipient. The ﬁndings
indicate that E. coli O25/ST131 is a stable subtype that does
not easily take up plasmids under optimal laboratory condi-
tions. Conjugal frequencies were also low for other ST/O type
donors, indicating that ESBL emergence with the presence of
blaCTX-M-15 is more likely to be caused by dissemination of ﬁt
subtypes rather than by conjugal transfer of blaCTX-M-15
between E. coli. The differences in conjugation frequencies
and O-type of the recipient suggest that the O-antigen could be
involved in the process of conjugation. Changes in LPS have
previously been found to inﬂuence conjugation frequencies,
10-5
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Figure 1 (A) Illustration of the observed difference in conjugation frequencies of recipients belonging to O25 compared to other O-types. (B) Difference in conjugation
frequency for one recipient depending on ampicillin selective pressure during conjugation. Statistics: Mann–Whitney test with application of Bonferroni correction to adjust
for multiple testing (α=0.017). Frequencies below the detection limit were not plotted. Horizontal lines represent medians.
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possibly by involvement in recipient cell recognition;22,23
however, further studies are necessary to enlighten this.
From a clinical aspect, the low conjugation frequencies
of E. coli ST131 to clinical fecal strains are appeasing. If
the widely prevalent ESBL-carrying bacterium is intro-
duced to a host environment without antibiotic selection
pressure it would, according to these results, not be likely
to pass on its resistance plasmid to fecal E. coli. We cannot
exclude that conjugation occurs with higher frequencies
between different species in vivo. This would increase the
overall gene-pool and further increase the risk of spread
and infection. However, arguing against this hypothesis is
our identiﬁcation of blaCTX-M-15 often linked to the chro-
mosome and not situated on a plasmid, despite being
present in isolates belonging to ST131/O25/ﬁmH30 with
IncF plasmid.
Conjugation frequencies under ampicillin pressure with
isolate KTE72 (O2/ST141) as recipient were 100-fold higher
than frequencies from experiments without antibiotics
(P=0.07) (Figure 1B). No transconjugants could be observed
with recipients KTE144 (O120/ST2797) and KTE168 (O2/
ST141) when subject to a sub-MIC concentration of ampicil-
lin. This indicates that sub-lethal antibiotic pressure may not
affect all E. coli conjugal frequencies, rather speciﬁc subtypes
and emphasizes the importance of antibiotic stewardship pro-
grams to minimize the spread of multidrug-resistant E. coli
such as O25/ST131/ﬁmH30 with blaCTX-M-15.
The genomic characterization of the recipient isolates
identiﬁed R/M-systems in all the isolates belonging to com-
mon ST types of the fecal E. coli microbiota. There was
overall no correlation between number of restriction-
modiﬁcation systems and the conjugation frequency; how-
ever, the ST131/O25 isolates all carried at least two R/
M-systems, which could perhaps explain why these isolates
were poor recipients of the ESBL-carrying plasmid. We
found no correlation between transfer frequencies and neither
Inc-groups nor restriction/modiﬁcation-systems (number and
type) of the recipients. Conjugation with these clinical strains
could occur even in recipients with three different R/
M-systems (based on in silico analyses), supporting previous
ﬁndings that presence of R/M-systems in recipients is not
a complete barrier for conjugation.24 On the other hand, the
presence of R/M-systems in all of the clinical fecal recipients
may contribute to the generally low conjugation frequencies
obtained and could be the reason why many of the conjuga-
tions were below the detection limit. Conclusively, in vivo
conjugation would be challenged similarly by the abundant
R/M-systems and could lower dissemination of ESBL-
resistance through plasmid conjugation. The laboratory strain
ALO1319 conjugated with similar frequencies despite lack of
R/M-systems (Table 1).
The number of experiments done with selective pres-
sure of ampicillin is very low. Further conjugation experi-
ments will be necessary to uncover the effect of ampicillin
on conjugation in more depth. Because of the limitations
of in vitro studies, it would be very relevant to repeat the
conjugation experiments in vivo, eg, in mice using clinical
E. coli strains.
Conclusion
In conclusion, this is the ﬁrst study to our knowledge
investigating conjugal recipient abilities of clinical
E. coli isolates of different sero- and ST-types.
Conjugation frequencies differed with O-type and ST
with signiﬁcantly lower frequencies with E. coli ST131
as recipients or donor, indicating that the worldwide high
prevalence of CTX-M-15-producing ST131 E. coli is not
likely caused by a conjugal spread of blaCTX-M-15 to sus-
ceptible O25/ST131 strains rather due to clonal dissemina-
tion. Plasmid transfer frequencies were higher for some
isolates under sub-MIC concentrations of ampicillin,
which demonstrates the need for proper antibiotic steward-
ship programs.
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Table S1 Genomic data on donors and recipients including sequencing method, mean coverage, number of contigs/scaffolds, genome
size, accession number
Isolate ID Seq. method Genome cov. Number of scaffolds Genome size Database Accession number
KTE6 PE+MP 143 4 5,213,369 GenBank NZ_ANVH00000000.1
KTE49 PE+MP 254 6 5,263,728 GenBank NZ_ANUC00000000.1
KTE64 PE+MP 135 15 5,266,965 GenBank NZ_ASUV00000000.1
KTE67 PE+MP 272 5 5,029,494 GenBank NZ_ANUM00000000.1
KTE72 PE+MP 120 15 5,219,548 GenBank NZ_ANUN00000000.1
KTE113 PE 169 87 5,026,156 GenBank NZ_ANXQ00000000.1
KTE114 PE+MP 142 12 4,754,090 GenBank NZ_ASTS00000000.1
KTE144 PE+MP 127 8 4,890,532 GenBank NZ_ANWL00000000.1
KTE165 PE+MP 139 3 4,757,839 GenBank NZ_ANWQ00000000.1
KTE168 PE 173 96 5,099,397 GenBank NZ_ANYM00000000.1
KTE171 PE+MP 138 11 4,859,600 GenBank NZ_ANVG00000000.1
Hvi138# PE+MP 345 17 5,298,611 ENA PRJEB32936
Hvi132# PE+MP 175 28 5,410,850 ENA PRJEB32936
Hvi09# PE+MP 104 17 5,425,536 ENA PRJEB32936
Hvi15# PE 52 128* 4,724,698 ENA PRJEB32936
Notes: *Number of contigs, #Sequenced for this study.
Abbreviations: MP, mate-pair; PE, paired-end.
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